Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4231604 | Journal of the American College of Radiology | 2011 | 6 Pages |
Abstract
The broadening of imaging capabilities and the increasing capacity of imaging to quantitate biologic processes has increased industry interest in using imaging methods in new drug development. Investigators participating in industry-sponsored trials should be aware of how such trials differ from investigator-initiated, grant-funded research. In particular, investigators should be cognizant of possible ethical conflicts in the care of patients, the development and analysis of data, and issues related to the dissemination of results.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Paul M. MD, PhD, Wim PhD,